'Depressed' Will Young wants to find God

... 'Depressed' Will Young wants to find God | the Daily Mail Weather Afternoon14ºC Evening7ºC Photo gallery Cheryl Tweedy has been named the sexiest footballers' wife.

See who she left in the shade...more Skip over navigation « Back to home Main sections Homepage News Sport Money TV & showbiz Showbiz video Columnists Live Night & Day Health YOU Femail Book club Horoscopes Travel Sudoku Weather Promotions Shopping E-editions Webchats Message boards Find a job Find a holiday Find a home Find a date Photos & video Quizzes Polls Competitions Contact us Need help?

Site map Log-in My details TV & showbiz Showbiz blog Headlines Showbiz video Jaci Stephen Baz Bamigboye Soaps and TV Photos & video Celebrity gossip Tickets & offers DVD rental Cinema search Webchats Message boards Partners Diet centre Mail wine club Tickets & offers Cancer cover Dating Money shop DVD rental Special promotions Ideal Home Show Yummy Mummy Millionaire's Megaprize All promotions » Mail extras GCSE league tables Primary school tables Security net Caption competitions Home delivery Mac cartoons Book club Email newsletters Photo galleries Celebrities in fur Sexy soccer wives London Fashion Week All galleries Showbiz quizzes Eurovision Soap exits Oscars 2006 More quizzes Advertorials Dulco-lax® Fertell fertility test Virgin cancer cover RSS feeds What is RSS?

All our RSS feeds Text-based site Accessibility Contact us Need help?

Site map Make us your homepage This site Business directory Advanced...

Pfizer's Lyrica Approved for the Treatment of Generalized Anxiety ...

... PharmaLive: Pfizer's Lyrica Approved for the Treatment of Generalized Anxiety Disorder in Europe DRUG APPROVALS Pfizer's Lyrica Approved for the Treatment of Generalized Anxiety Disorder in Europe An estimated 12 million patients in Europe suffer from generalized anxiety disorder, a common and chronic psychiatric disorder characterized by excessive worry and tension NEW YORK, March 27, 2006 /PRNewswire-FirstCall/ - Pfizer Inc said today that the European Commission has approved Lyrica(R) (pregabalin) for the treatment of generalized anxiety disorder (GAD) in adults.

In the European Union, it is estimated that nearly 12 million patients suffer from GAD on a yearly basis yet only one-third of these patients are properly diagnosed and even fewer received effective treatment.

Lyrica's approval was based on five randomized double-blind clinical trials involving over 2,000 patients.

Data from a combination of five placebo-controlled studies demonstrate that Lyrica provides rapid and sustained efficacy for the treatment of GAD.

As early as the first week of treatment, Lyrica was shown to be significantly effective in providing relief of both emotional symptoms, such as depressive symptoms and panic, as well as physical symptoms, including headaches and muscle aches.

"GAD is much more than the normal anxiety people experience under times of stress.

It is a chronic, debilitating illness that can greatly disrupt an individual's daily life, yet the disorder is under-treated," said D...

NumeriX Powers Brilliance with Front Office and Risk Management

... /*non nn4 styles*/ Bobsguide NumeriX The Guide to Software & Technology in Asset Management, Banking & Risk Management Add Company Become a Member About Us Contact Us Get our FREE Newsletter !

-FAQ- Search bobsguide.com !

- - !

- - !

- - Products or services Application Developer Program (ADP) NumeriX Library NumeriX FI Engine (CC) NumeriX CR Engine (Baskets) NumeriX CR Engine (Single Name) NumeriX F/X Engine Numerix FI Engine (Power Pricer) NumeriX FI Engine (Single Currency) NumeriX Toolkit NumeriX NumeriX is the global standard for cross-asset derivatives pricing and risk management.

Our cutting edge technology and advanced analytics empower buyers and sellers of derivatives to price and manage their risk with unprecedented Accuracy, Speed and Power.

News NumeriX Powers Brilliance with Front Office and Risk Management Capabilities NumeriX analytics to be fully integrated with Brilliance’s DealPoint NEW YORK, March 27 2006 – NumeriX, the leading player in multi-platform, cross-asset derivatives pricing and risk management software, today announced a partnership with Brilliance Software Corporation, a global provider and integrator of pricing and risk management systems for financial products.

Under the deal NumeriX’s analytics will be integrated with Brilliance’s pricing and risk management platform DealPoint.

The alliance follows strong market demand with particular interest in the pr...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news